Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Progression
100%
Heregulin
100%
ERBB2
100%
Breast Cancer Tumor
100%
Breast Cancer
33%
Estrogen
33%
Full-length cDNA
22%
Human Breast Cancer
22%
ErbB-2 Receptor
22%
Breast Cancer Cells
22%
Growth Hormone Receptor
22%
Signaling Pathway
11%
Mechanism of Action
11%
Hormone-independent
11%
Hormone-dependent
11%
Therapeutic Target
11%
Growth Factors
11%
Growth Effect
11%
In Vitro Cell Culture
11%
Oncogene Products
11%
Invasiveness
11%
Biochemical Systems
11%
Estrogen Receptor
11%
Therapeutic Implications
11%
Differentiation Factors
11%
Malignancy
11%
Signal Transduction
11%
Clinical Prognosis
11%
Resistant Phenotypes
11%
Treatment Regimen
11%
Antihormone
11%
Biological Effects
11%
Protein Sequence
11%
Alternative Splicing
11%
Breast Cancer Diagnosis
11%
Breast Cancer Prognosis
11%
Breast Cancer Patients
11%
Malignant Progression
11%
Constitutive Activation
11%
Mechanistic Aspects
11%
Hormone Resistant
11%
Small Proteins
11%
Targeted Therapy
11%
Cell Culture System
11%
Biological Endpoints
11%
Aggressive Phenotype
11%
Antidifferentiation
11%
Cancer Cells
11%
Diagnosis Treatment
11%
Estrogen-responsive
11%
Biphasic Growth
11%
Breast Cancer Treatment
11%
Overexpression
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Tumor Progression
100%
Neu Differentiation Factor
100%
Growth Factor Receptor
66%
Signal Transduction
66%
Oncogene
33%
Targeted Therapy
33%
Estrogen Receptor
33%
Hormone Dependence
33%
Biological Activity
33%
Cell Culture
33%
Peptide Sequence
33%
Growth Factor
33%
In Vitro Study
33%
Downregulation
33%
In Vivo Study
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neu Differentiation Factor
100%
Breast Cancer
100%
Tumor Growth
100%
Estrogen
40%
Complementary DNA
20%
Epidermal Growth Factor Receptor 2
20%
Growth Factor Receptor
20%
Growth Factor
10%
Cell Culture
10%
Receptor
10%
Prothrombin
10%
Estrogen Receptor
10%
Malignant Neoplasm
10%